CymaBay Therapeutics (CBAY)
NASDAQ:CBAY

CymaBay Therapeutics Stock News & Insights

1,243 Followers
Sujal Shah, President and CEO of CymaBay, stated, "Early in the third quarter we completed enrollment in RESPONSE, our global registration study of seladelpar in patients with PBC. This achievement ...Read more

News Score - Last 7 Days

Neutral
CBAY
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

Healthcare Stocks that are Trending in the News
RIGLRigel
HZNPHorizon Therapeutics
APENApollo Endosurgery
CINCCincor Pharma
IRMDIradimed
Showing the stocks with the most bullish news sentiment over the past week

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis